About 3-ketoacyl-CoA thiolase, mitochondrial
3-ketoacyl-CoA thiolase, mitochondrial (ACAA2) is a protein
from Homo sapiens identified by UniProt accession
P42765, 397 residues long.
MolForge cross-references it against 0 known binders and
100 disease associations.
Target properties
| Protein name | 3-ketoacyl-CoA thiolase, mitochondrial |
| UniProt accession | P42765 |
| Gene | ACAA2 |
| Organism | Homo sapiens |
| Length | 397 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (100)
Diseases linked to this target (Open Targets).
- refractive error measurement · score 0.25
- high density lipoprotein cholesterol measurement · score 0.23
- Myopia · score 0.23
- refractive error · score 0.23
- age at onset · score 0.22
- apolipoprotein A 1 measurement · score 0.19
- C-reactive protein measurement · score 0.17
- total cholesterol measurement · score 0.17
- mean corpuscular volume · score 0.15
- response to statin · score 0.15
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-P42765-F1 | alphafold | PREDICTED | 97.53 | — |
Amino-acid sequence (397 residues)
MALLRGVFVV AAKRTPFGAY GGLLKDFTAT DLSEFAAKAA LSAGKVSPET VDSVIMGNVL QSSSDAIYLA RHVGLRVGIP KETPALTINR LCGSGFQSIV NGCQEICVKE AEVVLCGGTE SMSQAPYCVR NVRFGTKLGS DIKLEDSLWV SLTDQHVQLP MAMTAENLAV KHKISREECD KYALQSQQRW KAANDAGYFN DEMAPIEVKT KKGKQTMQVD EHARPQTTLE QLQKLPPVFK KDGTVTAGNA SGVADGAGAV IIASEDAVKK HNFTPLARIV GYFVSGCDPS IMGIGPVPAI SGALKKAGLS LKDMDLVEVN EAFAPQYLAV ERSLDLDISK TNVNGGAIAL GHPLGGSGSR ITAHLVHELR RRGGKYAVGS ACIGGGQGIA VIIQSTA
Explore 3-ketoacyl-CoA thiolase, mitochondrial with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets